SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceutical sectors, is reinvesting in Archroma to support the Company’s ongoing initiatives to drive innovation, growth and operational efficiencies and to pursue strategic investments in both organic growth and industry consolidation.  Initially acquired

The Pracuj Group (Grupa Pracuj), a provider of Human Resources (HR) solutions that help companies recruit, retain, and develop employees in Central Europe, has secured a minority investment from TCV. TCV provides growth equity capital for both private and public technology companies in the US, Europe, and internationally. The Pracuj

Hastings Equity Partners (Hastings), a private equity firm focused on investing in lower, middle-market energy services and equipment companies, has made its ninth Fund III platform investment, in Reach Wireline (Reach).     Based in Fort Worth, Texas, Reach is a leading provider of Cased Hole Wireline services in the Permian,

DuPage Medical Group has closed the formation of a strategic partnership with funds managed by the private equity group Ares Management. The investment by Ares will enable continued support for growth initiatives across the entire organisation, including DMG’s practice management company, DMG Practice Management Solutions, and DMG’s subsidiary, Boncura Health

NorthEdge Capital has invested in Bridge Farm Nurseries (Bridge Farm), a producer of ornamental plants, flowers and herbs in the UK, backing a management buyout from its family shareholders. It is the first deal for the firm’s recently opened Midlands office. Founded in 1988 and headquartered in Spalding in Lincolnshire,

Private equity firm Calculus Capital, a leading EIS and VCT investor, has completed its third deal in two weeks, investing GBP2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells produced from reprogrammed human blood and tissue cells. Axol supplies high quality human cells – especially live human neurons

NGX Bio has closed a USD3 million funding round led by 180 Degree Capital Corp with participation from Third Kind Venture Capital, Lateral Capital, the Band of Angels and the Berkeley Angel Network, as well as other investors. NGX Bio was founded in 2014 to provide streamlined, on-line access to

SnapApp, provider of an SaaS platform used by B2B marketers to create, publish, and measure interactive content, has closed USD10.2 million in additional funding from its principal investor, Providence Strategic Growth, the growth equity affiliate of Providence Equity Partners. The Series B round follows a period of sustained and rapid

VentureMed Group (VMG), a medical device company developing and commercialising next-generation endovascular products to treat patients suffering from peripheral artery disease (PAD), has raised USD15 million in new equity financing. The Series B Round was led by new investor Endeavour Vision, a technology and life science investor based in Geneva,